Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers detail new studies and findings in the area of breast cancer
November 24th, 2005
Breast cancer data are the focus of recent research from Denmark, Canada and Japan. Study 1: Letrozole has been compared to endocrine therapy for breast cancer treatment in recent trials. "Endocrine therapy, predominantly using the antiestrogen tamoxifen, has long been a key treatment strategy for estrogen receptor-positive breast cancer," stated investigators in Denmark. "An alternative approach is to treat patients with aromatase inhibitors, which suppress estrogen biosynthesis." H. T. Mouridsen and colleagues explained, "Letrozole, and other third-generation aromatase inhibitors, are highly specific and potent inhibitors of...
Source: Women's Health Weekly (2005-11-24)
|
